Company Filing History:

9 out of 83

Synthon B.v.

Synthon Bct Technologies, LLC

patents

Years Active: 2002-2008

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7335380 - Amlodipine free base (2008-02-26),

2. 7329747 - Synthesis of olanzapine and intermediates thereof (2008-02-12),

3. 7199247 - Amide derivative of amlodipine (2007-04-03),

4. 7115638 - Amide derivative of amlodipine (2006-10-03),

5. 6965051 - Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith (2005-11-15),

6. 6858738 - Process for making amlodipine, derivatives thereof, and precursors therefor (2005-02-22),

7. 6835853 - Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith (2004-12-28),

8. 6830933 - Reference standards for determining the purity or stability of amlodipine maleate and processes therefor (2004-12-14),

9. 6703408 - N-formyl derivatives of paroxetine (2004-03-09),

10. 6686473 - Process for the production of paroxetine (2004-02-03),

11. 6653481 - Process for making amlodipine (2003-11-25),

12. 6645523 - Paroxetine compositions and processes for making the same (2003-11-11),

13. 6602893 - Amide derivative of amlodipine (2003-08-05),

14. 6562984 - Lactonization process (2003-05-13),

15. 6521758 - Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols (2003-02-18),

Title: The Inventor Spotlight: Theodorus H A Peters from Arnhem, Netherlands

Introduction:

Theodorus H A Peters, a prolific inventor hailing from Arnhem, Netherlands, has made significant contributions to the field with a total of 17 patents to his name. Known for his groundbreaking work in pharmaceutical formulations and synthesis processes, Peters continues to drive innovation in the industry.

Latest Patents:

1. Amlodipine Free Base: Peters' latest patent revolves around Amlodipine free base, a crucial component in the formulation of oral dosage forms. The technology allows for the creation of tablets without stickiness or residue, offering a convenient solution for medication delivery. The patent covers crystalline Form I and a novel Form II of Amlodipine free base, outlining methods for its production and utilization.

2. Synthesis of Olanzapine: Another notable patent by Peters involves the synthesis of Olanzapine and its intermediates. The process leverages an N-formyl olanzapine intermediate to produce Olanzapine and its salts efficiently. This patent underscores Peters' expertise in chemical synthesis and pharmaceutical manufacturing.

Career Highlights:

Throughout his career, Peters has made significant strides in the pharmaceutical industry. He has worked with esteemed companies such as Synthon B.V. and Synthon IP Inc., where he pioneered innovative solutions in drug development and formulation. Peters' dedication to advancing pharmaceutical technologies has earned him recognition as a leading figure in the field.

Collaborations:

Peters has collaborated closely with industry experts and researchers to bring his inventions to life. Among his notable coworkers are Jacobus Maria Lemmens and Franciscus B G Benneker, who have contributed to the success of various projects led by Peters. These collaborations have fueled creativity and ingenuity, leading to the development of groundbreaking pharmaceutical products.

Conclusion:

Theodorus H A Peters stands as a visionary inventor whose work has transformed the pharmaceutical landscape. With an impressive portfolio of patents and a commitment to innovation, Peters continues to push the boundaries of scientific discovery. His contributions to Amlodipine free base formulations and Olanzapine synthesis reflect his pioneering spirit and unwavering dedication to advancing the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com